BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2024 2:49:04 AM | Browse: 89 | Download: 309
 |
Received |
|
2024-01-10 13:50 |
|
Peer-Review Started |
|
2024-01-10 13:50 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-03-09 03:10 |
|
Revised |
|
2024-03-20 14:29 |
|
Second Decision |
|
2024-04-16 02:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-04-16 05:59 |
|
Articles in Press |
|
2024-04-16 05:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-14 12:43 |
|
Publish the Manuscript Online |
|
2024-06-15 02:49 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Aspirin suppresses hepatocellular carcinoma progression by inhibiting platelet activity
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-Jun Zhao, Zhi-Yin Wang, Wei-Ting Liu, Li-Li Yu, Hao-Nan Qi, Jie Ren and Chen-Guang Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chen-Guang Zhang, PhD, Professor, School of Public Health, Xinxiang Medical University, No. 601 Jinsui Road, Xinxiang 453003, Henan Province, China. 051085@xxmu.edu.cn |
| Key Words |
Platelets; Antiplatelet therapy; Hepatocellular carcinoma; Aspirin; Antitumor |
| Core Tip |
Previous studies have revealed the role of platelet plasma and its derivatives in tumorigenesis and development. Aspirin has also been shown to reduce the risk of hepatocellular carcinoma (HCC). However, the molecular mechanism of platelet action and whether aspirin can affect the progression of HCC by inhibiting platelet activity need to be further studied. Therefore, our study focused on exploring the functional mechanisms of platelets in the progression of HCC and using aspirin as an example to evaluate the application prospects of antiplatelet therapy. These findings will provide a potential strategy for the treatment of HCC and combination therapy. |
| Publish Date |
2024-06-15 02:49 |
| Citation |
<p>Zhao LJ, Wang ZY, Liu WT, Yu LL, Qi HN, Ren J, Zhang CG. Aspirin suppresses hepatocellular carcinoma progression by inhibiting platelet activity. <i>World J Gastrointest Oncol</i> 2024; 16(6): 2742-2756</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i6/2742.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i6.2742 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
